|  News |  Columns |  Reports |  Video Reviews |  Title History |  News Report |
// Chris Terrio to Write Justice League
// Eiza Gonzalez Instagrams a New Bikini-Clad Selfie
// Daniel Bryan Subdues a Burglar After Coming Home From Comic-Con
// [PODCAST] Leave The Memories Alone Top 10 Greatest UFC Events of All-Time
// Top 5 Wii Games


411mania RSS Feeds

Follow 411mania on Twitter!

Add 411 On Facebook

 411mania » MMA » News

NSAC Bans Therapeutic Use Exemptions For TRT
Posted by Jeremy Thomas on 02.27.2014

Nevada State Athletic Commission unanimously voted on Thursday to ban ban therapeutic-use exemptions for testosterone-replacement therapy. The ban, which was proposed by commissioner Raymond "Skip" Avansino, is effective immediately and all fighters, including ones previously granted exemptions, will not be allowed to apply for TUEs for fights in the state.

Avansino argued that the commission didn't have the resources to effectively monitor exemptions and NSAC chairman Francisco Aguilar concurred, noting that the exemption process was too resource-demanding with not enough payoff. The UFC has released a statement supporting the ban, which reads:

The Ultimate Fighting Championship fully supports the decision made today by the Nevada State Athletic Commission regarding the immediate termination of therapeutic use exemptions (TUE) for testosterone replacement therapy (TRT). We believe our athletes should compete based on their natural abilities and on an even playing field. We also intend to honor this ruling in international markets where, due to a lack of governing bodies, the UFC oversees regulatory efforts for our live events. We encourage all athletic commissions to adopt this ruling.

The ban will affect Vitor Belfort, who intended to apply for an exemption for his fight with Chris Weidman at UFC 173. Belfort has undergone TRT since 2011.

Credit: MMAjunkie


New Walking Dead Season 5 Trailer

Arrow Season 3 First Look Trailer

Top 7 Late Bloomers

comments powered by Disqus

Copyright (c) 2011 411mania.com, LLC. All rights reserved.
Click here for our privacy policy. Please help us serve you better, fill out our survey.
Use of this site signifies your agreement to our terms of use.